A research team has pioneered a groundbreaking method that could accelerate drug discovery and reduce pharmaceutical development costs. Their work introduces a safe, sustainable way to insert a single ...

Factors Affecting the Growth of the Artificial Intelligence For Drug Development and Discovery Industry: ...

In this interview, rare disease expert Oxana Iliach discusses challenges with rare disease drug development and how they can ...

While significant progress has been made in developing treatments for rare diseases—highlighted by the approval of over 800 drugs for orphan diseases since ...

U.S. pharmaceutical companies are increasingly licensing new drugs from China. Former FDA Commissioner Scott Gottlieb ...

Introduction: The Convergence of AI and Life SciencesTraditionally, drug discovery is a time-consuming and costly process, ...

Eli Lilly and Purdue University expand their partnership with a $250 million investment to advance pharmaceutical innovation ...

Iambic, a clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, published on major advances to Enchant, Iambic’s ...

The Global Drug Discovery Services Market is undergoing a major transformation, with the market forecast to grow rapidly from USD 21.87 billion in 2023 to USD 71.6 billion by 2032. This growth ...

A research team from the University of Oklahoma has pioneered a method that could accelerate drug discovery and reduce pharmaceutical development costs. Their work, published in the Journal of the ...

Iambic’s breakthrough multimodal transformer model for predicting clinical and preclinical endpoints related to the drug discovery and development process. This new version of Enchant marks a ...